Rapid production of clinical-grade SARS-CoV-2 specific T cells.

Rapid production of clinical-grade SARS-CoV-2 specific T cells.

10.1002/acg2.101

Saved in:

Bibliographic Details
Main Authors:	Leung, Wing, Soh, Teck Guan, Linn, Yeh Ching, Low, Jenny Guek-Hong, Loh, Jiashen, Chan, Marieta, Chng, Wee Joo, Koh, Liang Piu, Poon, Michelle Li-Mei, Ng, King Pan, Kuick, Chik Hong, Tan, Thuan Tong, Tan, Lip Kun, Seng, Michaela Su-Fern
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Format:	Article
Published:	Hindawi Limited 2022
Subjects:	COVID‐19 SARS‐CoV‐2 T Cells adoptive cell therapy
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/228757
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics
by: Chakraborty, Hirak, et al.
Published: (2021)

Memory T Cell Responses Targeting the SARS Coronavirus Persist up to 11 Years Post-Infection
by: Ng, Oi Wing, et al.
Published: (2016)

NMR structure and localization of a large fragment of the SARS-CoV fusion protein : implications in viral cell fusion
by: Pillay, Shubhadra, et al.
Published: (2019)

The spike and 3A proteins of severe acute respiratory syndrome coronavirus (SARS-CoV): Expressions and interactions in mammalian cells
by: SOONG POH LOONG
Published: (2010)

Autoimmune sequelae after Delta or Omicron variant SARS-CoV-2 infection in a highly vaccinated cohort
by: Wee, Liang En, et al.
Published: (2024)

Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
by: Siti Naqiah Amrun, et al.
Published: (2020)

The Effects of Heterologous Immunization with Prime-Boost COVID-19 Vaccination against SARS-CoV-2
by: Ho, Tzu-Chuan, et al.
Published: (2022)

SARS-CoV-2 Humoral Immunity Persists Following Rituximab Therapy
by: Lu, Liangjian, et al.
Published: (2023)

Factors affecting duration of SARS-Cov-2 viral shedding in mildly symptomatic patients isolated in a community facility
by: Cheng, Hui Mei, et al.
Published: (2021)

Longitudinal wastewater-based surveillance for SARS-CoV-2 in high-density student dormitories in Singapore
by: Ng, Wei Jie, et al.
Published: (2024)

The polybasic insert, the RBD of the SARS-CoV-2 spike protein, and the feline coronavirus – evolved or yet to evolve
by: Budhraja, Anshul, et al.
Published: (2022)

Disease prevalence matters: Challenge for SARS-CoV-2 testing
by: Lau, Chin-Shern, et al.
Published: (2022)

Screening, expression, and identification of nanobody against SARS-CoV-2 spike protein
by: Su, Qianling, et al.
Published: (2023)

Evaluation of a safe and sensitive Spike protein-based immunofluorescence assay for the detection of antibody responses to SARS-CoV
by: Manopo, I., et al.
Published: (2012)

Yeast expression and characterization of SARS-CoV N protein
by: Cao, S., et al.
Published: (2014)

Yeast expression and characterization of SARS-CoV N protein
by: Cao, S., et al.
Published: (2014)

Early pathogenesis profiles across SARS-CoV-2 variants in K18-hACE2 mice revealed differential triggers of lung damages
by: Aw, Zhen Qin, et al.
Published: (2023)

Density-based detection of cell transition states to construct disparate and bifurcating trajectories
by: Lan, T, et al.
Published: (2023)

A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro
by: Zhang, Haiping, et al.
Published: (2021)

Making waves: wastewater surveillance of SARS-CoV-2 in an endemic future
by: Wu, Fuqing, et al.
Published: (2022)

Environmental contamination of SARS-CoV-2 in a non-healthcare setting
by: Wong, Judith Chui Ching, et al.
Published: (2021)

Predicting potential SARS-CoV-2 spillover and spillback in animals
by: Tan, Zi Hian, et al.
Published: (2024)

Oligomerization-dependent beta-structure formation in SARS-CoV-2 envelope protein
by: Surya, Wahyu, et al.
Published: (2023)

Making waves : wastewater surveillance of SARS-CoV-2 for population-based health management
by: Thompson, Janelle R., et al.
Published: (2021)

Structural basis and function of the N terminus of SARS-CoV-2 nonstructural protein 1
by: Zhao, Kaitao, et al.
Published: (2022)

Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2
by: Chan, Yi-Hao, et al.
Published: (2022)

Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals
by: Goh, Yun Shan, et al.
Published: (2023)

Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
by: Amrun, S.N., et al.
Published: (2021)

Dicoumarol is an effective post-exposure prophylactic for SARS-CoV-2 Omicron infection in human airway epithelium.
by: Peng, Yang, et al.
Published: (2023)

SARS-CoV-2 titers in wastewater are higher than expected from clinically confirmed cases
by: Wu, F., et al.
Published: (2021)

A Virus-Specific Immune Rheostat in the Immunome of Patients Recovering From Mild COVID-19
by: Yeo, Joo Guan, et al.
Published: (2022)

Angiotensin-converting enzyme 2 in peripheral lung club cells modulates the susceptibility to SARS-CoV-2 in chronic obstructive pulmonary disease
by: Peng, Y, et al.
Published: (2022)

Evidence that the SARS-CoV-2 S protein undergoes a conformational change at the Golgi complex that leads to the formation of virus neutralising antibody binding epitopes in the S1 protein subunit
by: Wu, Yanjun, et al.
Published: (2024)

CHARACTERIZATION OF VIRAL-VIRAL AND VIRAL HOST INTERACTIONS THAT CONTRIBUTE TO THE REPLICATION AND PATHOGENESIS OF THE SEVERE ACUTE RESPIRATORY SYNDROME VIRUS (SARS-COV)
by: KENG CHOONG TAT
Published: (2011)

Modelling lockdown and exit strategies for COVID-19 in Singapore
by: DICKENS, BORAME SUE LEE, et al.
Published: (2021)

Co-incidence of BA.1 and BA.2 at the start of Singapore's Omicron wave revealed by community and university campus wastewater surveillance
by: Chua, Desmond Feng Jun, et al.
Published: (2023)

Performance of an automated chemiluminescent immunoassay for SARS-COV-2 IgM and head-to-head comparison of Abbott and Roche COVID-19 antibody assays
by: CS, L., et al.
Published: (2022)

Performance of two rapid point of care SARS-COV-2 antibody assays against laboratory-based automated chemiluminescent immunoassays for SARS-COV-2 IG-G, IG-M and total antibodies
by: Lau, C. S., et al.
Published: (2022)

The SARS coronavirus spike glycoprotein is selectively recognized by lung surfactant protein D and activates macrophages
by: Leth-Larsen, R., et al.
Published: (2011)

The impact of earlier reopening to travel in the Western Pacific on SARS-CoV-2 transmission
by: Jin, S, et al.
Published: (2023)